PRFX
NASDAQ · Pharmaceuticals
Prf Technologies Ltd
$2.30
+0.10 (+4.55%)
Open$2.18
Previous Close$2.20
Day High$2.30
Day Low$2.18
52W High$17.95
52W Low$2.27
Volume—
Avg Volume28.2K
Market Cap1.79M
P/E Ratio—
EPS$-166.27
SectorPharmaceuticals
Analyst Ratings
Strong Sell
6 analysts
Price Target
+420.0% upside
Current
$2.30
$2.30
Target
$11.96
$11.96
$8.59
$11.96 avg
$16.97
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 3.33M | 3.45M | 3.63M |
| Net Income | 722.6K | 805.0K | 796.5K |
| Profit Margin | 21.7% | 23.3% | 21.9% |
| EBITDA | 1.33M | 1.25M | 1.35M |
| Free Cash Flow | 449.2K | 396.5K | 453.1K |
| Rev Growth | -7.5% | +9.4% | +15.6% |
| Debt/Equity | 0.57 | 0.65 | 0.63 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |